Company Rexahn Pharmaceuticals, Inc. Nyse
Equities
US7616401011
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,813,370 | 23,942,205 ( 96.49 %) | 0 | 96.49 % |
Company contact information
Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road Suite 455
20850, Rockville
+(248) 957-9024
http://www.rexahn.comSector
1st Jan change | Capi. | |
---|---|---|
+10.44% | 107B | |
+0.82% | 106B | |
+8.12% | 23.47B | |
-13.89% | 21.9B | |
-6.13% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- Stock
- Stock
- Company Rexahn Pharmaceuticals, Inc.